Resultado de búsqueda
Andrew C. von Eschenbach (born October 30, 1941) was the Commissioner of the United States Food and Drug Administration from 2006 to 2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006.
6 de may. de 2021 · Andrew C. von Eschenbach, MD. The 2021 Pontifical Hero Award for Inspiration. for leadership in bridging the gap between science and faith. There are few people who embody the intersection of science, faith and public service more than Dr. Andrew von Eschenbach.
Andrew C. von Eschenbach is an advisor and former chairman of the Manhattan Institute’s Project FDA. In 2005–09, he was commissioner of the U.S. Food and Drug Administration, where he championed an agenda to modernize the FDA.
10 de jun. de 2015 · At the end of the day, I’m still a kid from South Philly,” Andrew C. von Eschenbach, MD, former Director of the National Cancer Institute (NCI) and Commissioner of the U.S. Food and Drug Administration (FDA), told The ASCO Post.
1 de feb. de 2002 · Dr. von Eschenbach brings a broad experience as a cancer surgeon, a very clear vision of the power of the new knowledge that cancer is a disease of altered genes, and a palpable passion for the rapid application of discovery to the immediate benefit of our patients.
6 de may. de 2021 · Andrew C. von Eschenbach, M.D., currently serves as president of Samaritan Health Initiatives. In September of 2005, he assumed leadership of the Food and Drug Administration where he immediately engaged an agenda to modernize the FDA.
Dr. Andrew von Eschenbach is the President and founder of Samaritan Health Initiatives, Inc., a health care policy consultancy, a role which he has held since 2010. He is also an Adjunct Professor at the University of Texas M.D. Anderson Cancer Center (“MDACC”), a position he has held since 2009.
